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Abstract 
Linear electrocardiographic lead transformations 
(LELTs) are used to estimate unrecorded ECG leads by 
applying a number of recorded leads to a LELT matrix. 
Such matrices are commonly developed using a training 
dataset. The size of the training dataset has an influence 
on the estimation performance of a LELT matrix. However, 
an estimate of the minimal size required for the 
development of LELTs has previously not been reported.  
The aim of this research was to determine such an 
estimate. We generated LELT matrices from differently 
sized (from n = 10 to n = 540 subjects in steps of 10 
subjects) training datasets. The LELT matrices and the 12-
lead ECG data of a testing dataset (n = 186 subjects) were 
used for the estimation of Frank VCGs. Root-mean-
squared-error values between recorded and estimated 
Frank leads of the testing dataset were used for the 
quantification of the estimation performance associated 
with a given size of the training dataset. 
The performance of the LELTs was, after an initial 
phase of improvement, found to only marginally improve 
with additional increases in the size of the training dataset. 
Our findings suggest that the training dataset should have 
a minimal size of 170 subjects when developing LELTs that 





Linear electrocardiographic (ECG) lead trans-
formations (LELTs) are used to estimate or derive 
unrecorded target leads by applying a number of recorded 
basis leads to a LELT matrix [1, 2].   
These LELTs are a well-established concept in 
computerized electrocardiology and are used in a wide 
range of different application areas.  Application areas of 
LELTs include the estimation of the Frank 
vectorcardiogram (VCG) using standard 12-lead ECG [3] 
or Mason-Likar 12-lead ECG data [1]. A further 
application area of LELTs is their use in reduced lead 
systems that estimate the 12-lead ECG from a reduced 
number of monitoring compatible ECG leads [4].  An 
emerging application area of LELTs is the performance 
assessment of patch based wearable electrocardiographic 
devices [5]. 
The most common form of LELTs utilizes 
transformation matrices that are designed to be used on 
ECG data of the general adult population.  Such 
transformation matrices are commonly developed using a 
training dataset that is composed of ECG data obtained 
from a number of different subjects.  For each of these 
subjects, one set of target leads and basis leads is included 
in the training dataset. The transformation matrices of 
LELTs are typically developed using multivariate linear 
regression analysis on the target leads and basis leads of 
the training dataset [1, 3].  The number of subjects whose 
ECGs are included in the training dataset is commonly 
referred to as the size of the training dataset.  
It is desirable that the transformation matrices of LELTs 
are capable of producing accurate estimates of the target 
leads for all members of the adult population.  The 
utilization of unrepresentative and small training datasets 
is known to yield transformation matrices that perform 
poorly in the general adult population.  Training datasets 
should therefore be of sufficient size in an attempt to 
accurately reflect the statistical relationship between the 
basis leads and the target leads of the general population.  
Recording a large training dataset for the development 
of a new transformation matrix is potentially a time and 
cost expensive procedure.  It would therefore be desirable 
to know an estimate of the minimal training dataset size 
that is required for the development of LELT matrices.  
However, such an estimate has, to the best of our 
knowledge, not previously been reported in the literature. 
The aim of this research is to determine an estimate of 
the minimal training dataset size required for the 
development of LELTs. To this end, we assess the 
estimation performance of LELT matrices developed using 
training datasets of increasing size. We define the minimal 
required size of the training dataset as a size, at which only 
marginally improvements in the performance of a LELT 
matrix can be achieved through further increases in the size 
of the training dataset.    
2. Material and methods 
2.1. Study population 
We base our research on a study population of 726 
subjects.  The study population is composed of 229 normal 
subjects, 265 subjects with myocardial infarction and 232 
subjects with left ventricular hypertrophy. The study 
population was randomly partitioned into a test dataset 
(𝐷𝑇𝑒𝑠𝑡) of fixed size and a pool of 540 subjects (𝐷𝑇𝑟𝑎𝑖𝑛) 
that were used to assemble training datasets of varying 
size. Table 1 details the composition of 𝐷𝑇𝑒𝑠𝑡 and 
𝐷𝑇𝑟𝑎𝑖𝑛. 
 
Table 1.  Composition of the test data (𝐷𝑇𝑒𝑠𝑡) and the 
train data (𝐷𝑇𝑟𝑎𝑖𝑛). 
 Normal MI LVH Total 
𝐷𝑇𝑒𝑠𝑡 59 66 61 186 
𝐷𝑇𝑟𝑎𝑖𝑛 170 199 171 540 
Notes. Normal, Subjects with no abnormalities in their 
ECGs; MI, Subjects with myocardial infarction; LVH, Subjects 
with left ventricular hypertrophy. 
2.2. Target and basis leads of the LELTs 
The eight independent leads I, II, V1 to V6 of the 
standard 12-lead ECG were chosen as the basis lead set for 
the LELT matrices that were assessed in this research.  
This was because the standard 12-lead ECG is the most 
widely adopted ECG recording format [6], which makes 
the standard 12-lead ECG a popular basis lead set that is 
used in different LELTs. 
The heart-vector model [7] of the cardiac electrical 
activity provided the rational for the utilization of the 
Frank VCG as the target lead set for the LELT matrices 
assessed in this research. Any ECG lead can, in accordance 
with the heart-vector model, be expressed as a weighted 
sum of the orthogonal X, Y and Z leads used by the Frank 
VCG.  The minimal size of the training dataset required for 
the development of a LELT matrix, that is used for the 
estimation of the Frank VCG, was therefore regarded as a 
good estimate of the minimal training size required for the 
development of any other LELT matrix. 
2.3. BSPM data 
One body surface potential map (BSPM) was recorded 
for each of the 726 subjects in the study population. Each 
BSPM used in this research contains electrocardiographic 
data of 120 BSPM leads.  A representative average  
QRS-T complex was calculated for each of the 120 BSPM 
leads.  Three of the 120 leads were recorded from 
electrodes placed on the right and left wrist and the left 
ankle (VR, VL and VF respectively).  Electrodes situated 
at 81 anterior and 36 posterior locations were used to 
record 117 thoracic leads.  All thoracic leads were recorded 
with reference to the Wilson central terminal (WCT).  A 
comprehensive description of the BSPM data and the 
recording procedure can be found in [8]. A Laplacian 3D 
interpolation procedure [9] was applied to the 117 thoracic 
BSPM leads.  This was performed to obtain body surface 
potentials at the locations of the 352 Dalhousie torso [10] 
nodes.   
2.4. Frank VCG data 
One Frank VCG [11] was extracted from each of the 
726 BSPMs. First, body surface potentials at the A, C, E, 
F, H, I and M electrode locations of the Frank lead system 
were extracted from the interpolated BSPM data. Body 
surface potentials from body locations that were not a 
direct subset of the 352 Dalhousie torso nodes were 
obtained using linear interpolation [12].  Second, the body 
surface potentials at the Frank electrode locations were 
used to derive the Frank VCG using (1). 
𝑽𝑪𝑮 = [𝑿, 𝒀, 𝒁] = [𝝋𝑨, … , 𝝋𝑴 ] ∙ 𝑨
𝑻 . (1) 
Where 𝝋𝑨, 𝝋𝑪, 𝝋𝑬, 𝝋𝑭, 𝝋𝑯, 𝝋𝑰, and 𝝋𝑴 are 𝑛 × 1 
vectors that contain 𝑛 sample values of potentials at the 
Frank electrode locations A to M respectively, [∙]𝑻 refers 
to the transpose of a matrix, 𝑛 denotes the number of 
samples in the average QRS-T complex, 𝑨  is a 3 × 7 
matrix of published coefficients [13] that allow for a 
derivation of the Frank VCG using the potentials 𝝋𝑨 to 
𝝋𝑴, and 𝑽𝑪𝑮
  is a 𝑛 × 3 matrix containing 𝑛 sample 
values of the Frank VCG, the 𝑛 × 1 vectors 𝑿, 𝒀 and 𝒁 
contain 𝑛 sample values of the three Frank leads X, Y and 
Z respectively. 
2.5. Standard 12-lead ECG data 
One standard 12-lead ECG was extracted from each of 
the 726 BSPMs. First, body surface potentials recorded at 
the wrists and ankles were used to calculate the limb leads 
of the standard 12-lead ECG as well as the potential at the 
WCT.  Second, the body surface potentials at the 
electrode locations associated with the precordial leads 
were extracted from the interpolated BSPM data. 
Required body surface potentials from locations that were 
not a direct subset of the 352 Dalhousie torso nodes were 
obtained using linear interpolation.  Third, average QRS-
T complexes of the precordial leads were calculated in 
reference to the WCT using body surface potentials 
obtained from the locations of the precordial electrodes. 
2.6. Linear regression based ECG lead 
transformation matrices 
The data in 𝐷𝑇𝑟𝑎𝑖𝑛 was used to assemble training 
datasets of different sizes.  More precisely, training 
datasets staring from n = 10 to n = 540 subjects were 
generated in steps of 10 subjects.  Random sampling with 
replacement was used to compose 200 different instances 
of each training dataset size using the data in 𝐷𝑇𝑟𝑎𝑖𝑛.  The 
different training dataset instances were used to generate a 
total of 200 transformation matrices for each training 
dataset size.  Transformation matrices that allow for the 
estimation of the Frank VCG from the standard 12-lead 
ECG were developed using the multivariate linear 
regression based approach in (2). 
𝑨𝑽𝑪𝑮𝒊𝒎












Where [∙]𝑻  and [∙]−𝟏denote the transpose and the 
inverse of a matrix respectively, 𝑨𝑽𝑪𝑮𝒊𝒎
  refers to a 8× 3 
matrix of transformation coefficients that allows for the 
transformation of the eight independent leads I, II and V1 
to V6 of the standard 12-lead ECG into the Frank VCG, 
𝑚 ∈ {10, … ,540} denotes the size of the training dataset, 
𝑛 refers to the number of QRS-T sample values in the 
training dataset of size 𝑚, 𝑖 ∈ {1, … ,200} denotes the 




𝒊 refers to a n× 3 matrix 
that contains 𝑛 sample values of the X, Y and Z leads of 
the Frank VCG and 𝑺𝟏𝟐𝑳𝒎
 
𝒊 refers to a n× 8 matrix that 
contains 𝑛 sample values of the eight independent leads I, 
II and V1 to V6 of the standard 12-lead ECG. 
2.7. Derivation of the target leads 
The 𝑨𝑽𝑪𝑮𝒊𝒎
  matrices were used to derive the target 
leads of the 186 subjects in 𝐷𝑇𝑒𝑠𝑡.  This was performed 
using the approach in (3) and for all LELT matrices with 
𝑖 ∈ {1, … ,200} and 𝑚 ∈ {10, … ,540}. 
𝒅𝑽𝑪𝑮𝒊𝒎
 = 𝑺𝟏𝟐𝑳 
 ∙ 𝑨𝑽𝑪𝑮𝒊𝒎
 . (3) 
Where 𝑨𝑽𝑪𝑮𝒊𝒎
 , 𝑚 and 𝑖 are as defined in (2), 𝑺𝟏𝟐𝑳 
  is 
a 𝑛 × 8 matrix that contains the n sample values of the 
QRS-T complex for the eight independent leads of the 
standard 12-lead ECG of one subject in 𝐷𝑇𝑒𝑠𝑡 and 
𝒅𝑽𝑪𝑮𝒊𝒎
  is 𝑛 × 3 matrices that contain the derived leads of 
the Frank VCG.  
2.8. Performance assessment 
The average performance of each 𝑨𝑽𝑪𝑮𝒊𝒎
  matrix was 
quantified using the data of the 186 subjects in 𝐷𝑇𝑒𝑠𝑡.  
First, root mean square error (RMSE) values were 
calculated between the QRS-T complexes of the recorded 
and the derived target leads. This was performed for each 
transformation matrix and for each of the 186 subjects in 
𝐷𝑇𝑒𝑠𝑡. Second, the mean of the 186 different RMSE 
values associated with each target lead and 𝑨𝑽𝑪𝑮𝒊𝒎
  matrix 
was determined for each 𝑖 ∈ {1, … ,200} and 𝑚 ∈
{10, … ,540}.  The outcome of this performance 




elements.  Where each  𝑽𝑪𝑮̅̅ ̅̅ ̅̅𝑚
𝑅𝑀𝑆𝐸
𝑖
  contains one mean 
RMSE value for each of the three Frank VCG leads, 𝑖 ∈
{1, … ,200} and 𝑚 ∈ {10, … ,540}  respectively denote the 
instance and size of the training dataset hat was used for 
the development of the 𝑨𝑽𝑪𝑮𝒊𝒎
  matrix associated with the 




2.9. Determination of the minimal size 
required for the training dataset 
The minimal required size of the training dataset was 
determined separately for each Frank lead using two 
different criteria. Both criteria defined the minimal 
required size using mean  𝑽𝑪𝑮̅̅ ̅̅ ̅̅𝑚
𝑅𝑀𝑆𝐸
𝑖
  values that were 
calculated over all 𝑖 ∈ {1, … ,200} instances of a given 
training dataset size 𝑚. 
The first criterion was based upon right-tailed t-tests 
(significance level alpha = 0.05) that were used to test the 
null hypothesis, that the mean  𝑽𝑪𝑮̅̅ ̅̅ ̅̅𝑚
𝑅𝑀𝑆𝐸
𝑖
  value associated 
with a given training dataset size 𝑚 was equal or less than 
101% of the mean  𝑽𝑪𝑮̅̅ ̅̅ ̅̅540
𝑅𝑀𝑆𝐸
𝑖
  value.  This test was 
performed for each training dataset size 𝑚 ∈ {10, … ,540}.  
A failure to reject the null hypothesis corresponds to a lack 
of statistical evidence that the mean  𝑽𝑪𝑮̅̅ ̅̅ ̅̅𝑚
𝑅𝑀𝑆𝐸
𝑖
  value 
associated with a given training size 𝑚 is at least +1% 
greater than the mean  𝑽𝑪𝑮̅̅ ̅̅ ̅̅540
𝑅𝑀𝑆𝐸
𝑖
  value.  The smallest size 
𝑚 at which a t-test failed to reject the null hypothesis was 
considered as the minimal required training dataset size 𝑚.   
The second criterion for defining the minimal required 
size of the training dataset was based upon reaching 95% 
of the reduction in the mean  𝑽𝑪𝑮̅̅ ̅̅ ̅̅𝑚
𝑅𝑀𝑆𝐸
𝑖
  value that was 
observed between the smallest (m = 10 subjects) and the 
largest (m = 540 subjects) training dataset size.  First, the 
difference between the mean  𝑽𝑪𝑮̅̅ ̅̅ ̅̅10
𝑅𝑀𝑆𝐸
𝑖
  value and the 
mean  𝑽𝑪𝑮̅̅ ̅̅ ̅̅540
𝑅𝑀𝑆𝐸
𝑖
  value was calculated.  This difference 
was regarded as the maximal reduction in the mean 
 𝑽𝑪𝑮̅̅ ̅̅ ̅̅𝑚
𝑅𝑀𝑆𝐸
𝑖
  value that can be achieved when increasing the 
size of the training dataset from 10 to 540 subjects.  








value were calculated. Third, these differences were 
expressed as percentage of the maximal reduction in the 
mean  𝑽𝑪𝑮̅̅ ̅̅ ̅̅𝑚
𝑅𝑀𝑆𝐸
𝑖
  value. Fourth, a right-tailed t-test 
(significance level alpha = 0.05) was used to test the null 
hypothesis, that the remaining reduction in the mean 
 𝑽𝑪𝑮̅̅ ̅̅ ̅̅𝑚
𝑅𝑀𝑆𝐸
𝑖
  value was equal or less than 5 % of the 
maximal observed reduction.  This test was performed for 
each training dataset size 𝑚 ∈ {10, … ,540}.  A failure to 
reject the null hypothesis corresponds to a lack of statistical 




value was greater than 5 % of the maximal value.  The 
smallest size 𝑚 for which this test was not able to reject 
the null hypothesis was considered as the minimal required 
training dataset size 𝑚. 
3. Results 
A summary of the findings from the analysis of the 
minimal required size of the training dataset is provided in 
Table 1. 
Table 1. Minimal required training dataset sizes for each 
Frank VCG lead and mean  𝑽𝑪𝑮̅̅ ̅̅ ̅̅𝑚
𝑅𝑀𝑆𝐸
𝑖
  values associate 












1% of final value 170 30.4 
30.0 
95 % reduction 170 30.4 
Y 
1% of final value 120 30.8 
30.3 
95 % reduction 130 30.7 
Z 
1% of final value 130 47.6 
46.9 
95 % reduction 130 47.6 
acriterion used for the determination of the minimal required 
training dataset size; bmean  𝑽𝑪𝑮̅̅ ̅̅ ̅̅𝑚
𝑅𝑀𝑆𝐸
𝑖
  value in µV associated 




value in µV for a training dataset size of 540 subjects. 
4. Discussion and conclusion 
This paper reported on the assessment of the minimal 
training dataset size that is required for the development of 
LELT matrices.  Our analysis was conducted on LELT 
matrices that transform the standard 12-lead ECG into the 
Frank VCG. A minimal training dataset size of 170 
subjects, 130 subjects and 130 subjects was found to be 
sufficient for the estimation of Frank leads X, Y and Z 
respectively.  Any ECG lead can, in accordance with the 
heart-vector model [7], be expressed as a weighted sum of 
the orthogonal Frank X, Y and Z leads. We therefore 
conclude that a training dataset size of 170 subjects should 
be sufficient for the development of LELTs that utilize the 
12-lead ECG for the estimation any ECG lead that can be 
recorded from the body surface.   
A limitation of this research is that the assessed LELT 
matrices were developed and tested on ECG data that was 
obtained from three equally represented cohorts (normal 
subjects, subjects with myocardial infarction and subjects 
with left ventricular hypertrophy). Whether the presence of 
different additional cardiac disorders in the training and 
testing datasets would have an influence on the required 
minimal training dataset size has not been assessed in this 
research.  
A further limitation of this research is that it has solely 
assessed the influence of the training dataset size on the 
mean estimation performance (mean  𝑽𝑪𝑮̅̅ ̅̅ ̅̅𝑚
𝑅𝑀𝑆𝐸
𝑖
  value).  
This is a limitation as the assessed LELT matrices were 
intended to be used with all members of the adult 
population. Such matrices should therefore not only have 
an acceptable mean estimation performance but should 
ideally also perform equally well for all members of the 
adult population. The subject-to-subject variability of the 
estimation performance of a LELT matrix is therefore an 
additional performance metric that has to be considered. 
Future research should thus investigate the influence of the 
training dataset size on this subject-to-subject variability. 
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